Clinical trial
Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation
NCT04775264 is registered in ClinicalTrials.gov with Atrian Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation
- Lead sponsor
- Atrian Medical Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 17, 2021
- Completion date
- April 27, 2023
- Enrollment
- 24 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.